MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Edwards Lifesciences’ Sapien sales grow 11.5% in Q1

Edwards Lifesciences’ Sapien sales grow 11.5% in Q1

By

TAVI: Edwards' Sapien sales gain 11.5% in Q1

Medtech giant Edwards Lifesciences (NYSE:EW) posted Street-beating figures for its 1st quarter, driven largely by growth in its transcatheter heart valves.

Sales of its Sapien suite of valves grew 11.5% year-over-year, contributing to a 2.7% increase in adjusted per-share earnings, which beat analysts’ expectations by 7¢. Total revenues increased 5.3% during Q1, but fell just shy of analysts estimates.

The California company has been making headlines this year, with regulatory wins that expanded its portfolio of Sapien THV devices. The company also got lots of ink over a long-running patent infringement battle with arch-rival Medtronic (NYSE:MDT).

Edwards recorded $5.5 million in legal fees associated with intellectual property litigation during its 1st quarter of 2014. During the same time last year the company had touted a special pre-tax gain of $83.6 million as Medtronic made initial payments associated with the ongoing patent battle.

In total Edwards posted profits of $60.3 million, or 56¢ per diluted share, on sales of $522.4 million during the 3 months ended March 31. That compared with profits of $143.9 million, or $1.24 per share, on sales of $496.7 million during the same period last year.

Excluding special charges, Edwards reported 76¢ in adjusted per-share earnings.

The news preceded a minor boost in Edwards’ shares, which gained 1.6% since the earnings report came out on Thursday. Shares were trading at $80.58 apiece as of about 1:10 p.m. EST today, up 0.4% on the day.

In case you missed it

RSS From Medical Design & Outsourcing

  • 6 power management considerations for developing and scaling smaller, smarter micromedical devices
    Supercharge every phase of micromedical device product development with these questions. Mitch Johnson, Intricon Some of the biggest considerations for designing, manufacturing and scaling today’s smaller, smarter medical innovations center on providing power to microelectronic systems. From mechanical functionality to data operations and wireless communications, effective power management drives continued device innovation. Addressing five fundamental… […]
  • Evonik, Coopmed agree on wound dressing distro deal
    Evonik announced today that it signed an agreement for medical technology company Coopmed to distribute the epicite wound dressing. Jena, Germany-based Evonik said Coopmed will distribute the epicite dressing made from biosynthetic cellulose exclusively to the German market for chronic wound care. Epicite represents part of the portfolio from JeNaCell, which Evonik acquired in 2021.… […]
  • Spartech hires Bosch VP Dan Gallo as chief operating officer
    Spartech today said it hired Dan Gallo as chief operating officer of the engineered thermoplastics and custom packaging manufacturer. Gallo started this month, according to his LinkedIn page. His career leading operations, supply chain and logistics functions spans more than three decades. He was most recently an operations VP at Robert Bosch. Before his time… […]
  • 3M launches Verify platform to spot counterfeit products
    3M (NYSE:MMM) announced today that it established a new 3M Verify platform to report potential counterfeit 3M products. The effort builds upon its anti-counterfeit efforts during the height of the COVID-19 pandemic. At the time, a number of sellers claimed to offer 3M respirators. Instead, many offered fake, defective and damaged N95 masks at inflated… […]
  • FDA will review fewer COVID-19 test EUA submissions
    The FDA is pushing COVID-19 test developers away from emergency use authorization (EUA) submissions in favor of more traditional pathways, the agency said today. The FDA said it intends to review “only a small subset” of new EUA submissions, encouraging test makers to seek regulatory approval through de novo classification or 510(k) clearance pre-market review… […]
  • Integra plans to shrink the C-suite after executive’s exit
    Integra Lifesciences (Nasdaq: IART) will eliminate the position of chief operating officer next week — though the office is already empty. Former COO Glenn Coleman’s last day at Integra was Friday, according to a separation agreement filed with the Securities and Exchange Commission that same day. Coleman was scheduled to start as the new EVP and… […]
  • Steris plans to build a new medical device testing facility
    Steris (NYSE: STE) plans to build a new packaging and microbiological testing facility for medical devices in Leipzig, Germany. The facility will offer packaging testing services such as accelerated and real-time aging, transportation and integrity testing. The new location will also offer microbiological testing in collaboration with the medical device manufacturer and sterilizer’s laboratory in… […]
  • 10 medical device startups you need to know
    Some of the most interesting medical device startups of 2022 are advancing a wide range of innovative medtech: robotics, catheter-delivered brain-computer interfaces and more. The editors here at Medical Design & Outsourcing and MassDevice are writing about medical device startups all the time. But there are some device companies starting out that have technologies that… […]
  • Steris stock downgraded as analysts expect lawyers to seek more ethylene oxide lawsuits
    Steris (NYSE: STE) stock was downgraded today by Needham from buy to hold following the $363 million jury verdict against its primary competitor, Sterigenics, over ethylene oxide (EtO) emissions. Needham analysts said they expect attorneys to target communities near EtO facilities with ads to find people willing to file more lawsuits against sterilization plant operators… […]
  • Researchers develop at-home device to track Parkinson’s progression
    Researchers at MIT and the University of Rochester Medical Center have developed a device to monitor a Parkinson’s patient at home. Collecting data at home could help provide a less subjective measurement than evaluations at the doctor’s office, which can be affected by outside factors. The technology could also help pharmaceutical and biotech companies developing… […]
  • Micro Mold renovates for new 5-axis milling center
    Precision mold maker Micro Mold has renovated in Erie, Pennsylvania, to make room for its new Yasda YMC650 high-speed 5-axis milling center and 3R Workpartner automation cell. The new equipment will be used for electrode manufacturing and finishing hard mill applications. The milling machine is accurate to 1 micron for high-volume, ultra-precision tooling work, the… […]

Leave a Reply